Resveratrol After 40: Promise, Hype and What Human Studies Show

Resveratrol became famous as the red-wine compound that might slow aging. Headlines in the mid-2000s promised exercise benefits in a pill, and sales soared among people entering midlife. Our editorial team looks at what happened when researchers moved from mice to humans, and whether resveratrol deserves a place in the routine of an active adult over 40.
Where the Excitement Came From
Resveratrol is a polyphenol produced by certain plants, including grapes, peanuts and Japanese knotweed, in response to stress or fungal infection. Most commercial supplements are extracted from knotweed or produced synthetically.
Interest exploded after laboratory studies linked resveratrol to sirtuins, enzymes involved in cellular stress responses and associated with the benefits of calorie restriction in some organisms. The idea that a single molecule could mimic calorie restriction was irresistible.
In 2006, Baur and colleagues reported in Nature that resveratrol improved health and survival in mice fed a high-calorie diet. The same year, other mouse studies suggested improved endurance and mitochondrial function. Media coverage presented these results as a potential anti-aging breakthrough.
Subsequent research questioned whether resveratrol activates sirtuins directly or through indirect pathways such as AMPK. The mechanistic debate continues, but the more important question for consumers is what happens in people.
The Bioavailability Problem
Walle and colleagues (2004) showed that oral resveratrol is well absorbed — about 70% — but is rapidly metabolized in the intestine and liver into sulfate and glucuronide conjugates. As a result, very little free resveratrol reaches the circulation.
This raises a fundamental issue: the concentrations used in cell culture studies are often far higher than anything achievable in human blood after a supplement. Effects seen in a dish may not translate to the body.
Manufacturers have responded with micronized powders, liposomal forms and combinations with piperine. Some of these increase blood levels, but whether higher levels produce meaningful health benefits remains unproven.
The amount of resveratrol in red wine is small — typically well under a few milligrams per glass — so wine cannot be considered a practical source. Alcohol's own risks outweigh any theoretical polyphenol benefit.

Human Trials on Metabolism
Results in humans have been mixed. Timmers and colleagues (2011) gave 150 mg/day of resveratrol for 30 days to obese men and reported modest calorie-restriction-like changes, including lower blood pressure and improved metabolic markers.
In contrast, Poulsen and colleagues (2013) used a much higher dose of 1,500 mg/day for four weeks in obese men and found no improvement in insulin sensitivity, energy expenditure or body composition. Differences in dose, population and design make direct comparison difficult.
| Study | Population | Daily dose in study | Main finding |
|---|---|---|---|
| Timmers et al., 2011 | Obese men | 150 mg, 30 days | Modest metabolic improvements |
| Poulsen et al., 2013 | Obese men | 1,500 mg, 4 weeks | No effect on insulin sensitivity |
| Gliemann et al., 2013 | Physically inactive men about 65 | 250 mg + training, 8 weeks | Blunted cardiovascular training benefits |
| Olesen et al., 2014 | Same cohort, muscle analysis | 250 mg + training | Training, not resveratrol, improved muscle markers |
Overall, meta-analyses suggest small and inconsistent effects on blood glucose, blood pressure and cholesterol, often limited to people with existing metabolic disease. Healthy, active adults in their forties are unlikely to see measurable changes.
Resveratrol and Exercise: A Potential Conflict
For active people, the most important finding comes from Denmark. Gliemann and colleagues (2013) randomized older men to eight weeks of high-intensity training with either 250 mg/day of resveratrol or placebo.
Training improved maximal oxygen uptake, blood pressure and cholesterol in the placebo group, but the resveratrol group showed smaller or absent improvements in several cardiovascular markers. Olesen and colleagues (2014), analyzing muscle samples from the same study, concluded that exercise, not resveratrol, drove the beneficial changes.
This mirrors research on high-dose vitamins C and E, which in some studies blunted training adaptations. Exercise works partly through short bursts of oxidative stress that trigger adaptive signaling; strong antioxidants may dampen these signals.
The finding does not mean resveratrol is harmful for everyone, but it challenges the idea that it adds to exercise benefits. For people who train specifically to improve cardiovascular fitness after 40, the evidence argues against routine supplementation.
Safety and Practical Considerations
- Digestive effects: doses above roughly 1 g/day commonly cause nausea, cramping and diarrhea.
- Drug interactions: resveratrol may affect platelet function and liver enzymes; caution with anticoagulants and antiplatelet drugs.
- Hormone-sensitive conditions: resveratrol has weak estrogen-like activity in lab studies; women with hormone-sensitive cancers should consult their oncologist.
- Product quality: as a US dietary supplement, resveratrol is not reviewed for potency; look for third-party verified products.
- Surgery: stopping before procedures is often advised because of possible bleeding effects.
Most human studies have used doses between 150 mg and 1,500 mg per day for weeks to months. Long-term data in healthy adults over many years are limited, so claims of lifelong anti-aging benefit remain speculative.
A diet rich in colorful plants — berries, grapes, nuts, legumes and vegetables — delivers a broad spectrum of polyphenols along with fiber and other nutrients. This pattern has much stronger evidence for healthy aging than any single isolated compound.
If an adult over 40 still wants to try resveratrol, it makes sense to discuss it with a physician, avoid taking it around key training sessions, and evaluate whether it produces any measurable difference.
Editorial Team Conclusions
Resveratrol's reputation was built on animal and cell studies. In humans, low bioavailability and inconsistent trial results have tempered expectations considerably.
For active adults over 40, the strongest signal is cautionary: in older men, resveratrol appeared to blunt some cardiovascular benefits of training. Exercise, sleep and a plant-rich diet remain far more reliable tools for healthy aging.
Our editors also recommend articles on antioxidants and training adaptations, omega-3 fatty acids after 40, and the evidence behind NAD+ precursors.
References
- Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337–342.
- Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32(12):1377–1382.
- Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14(5):612–622.
- Poulsen MM, Vestergaard PF, Clasen BF, et al. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes. 2013;62(4):1186–1195.
- Gliemann L, Schmidt JF, Olesen J, et al. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol. 2013;591(20):5047–5059.
- Olesen J, Gliemann L, Biensø R, Schmidt J, Hellsten Y, Pilegaard H. Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men. J Physiol. 2014;592(8):1873–1886.


